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Background
Nearly 40% of the patients presenting with ST Elevation
Myocardial Infarction (STEMI) have multivessel disease
(MVD). Currently ESC and the ACC/AHA guidelines
recommend revascularization of the culprit artery only.
2 recent trials (PRAMI and CVLPRIT) have shown a
superiority of complete in-hospital revascularisation as
compared to culprit only treatment. Although the mor-
tality in the 2 groups in the trials were not significantly
different but the composite end point was, which was
mainly driven by ischaemia.
Aim
To assess the role of stress CMR as a gatekeeper to
complete revascularisation in STEMI patients with mod-
erate to severe bystander disease, treated with Primary
PCI (PPCI) of the culprit lesion.
Methods
The study was performed from the data collected on
consecutive patients who underwent PPCI between Sep-
tember 2011 - September 2013 at a tertiary centre in
the South-West of England. A non-culprit lesion was
considered to be moderate to severe if the stenosis was
50-75% in large proximal epicardial vessel or 70-90%
elsewhere. Severe or critical bystander disease was
excluded as the best treatment for those was deemed to
be direct revascularisation without Fractional Flow
reserve (FFR) assessment. The diagnostic accuracy of
stress CMR was assumed 88% and FFR 100%. A simple
cost analysis model was created with the data collected
from stress CMR examinations and using the result in
an FFR guided strategy. The United Kingdom or United
States cost for each investigation used in the model is
shown in table 1.
Results
1,167 patients were included (74% males with a mean
age 64 years). Significant MVD was present in 391
patients (33%). 157/391 (40%) underwent stress CMR
guided approach. The remaining 234 patients either
underwent direct revascularisation (presence of severe
or critical stenosis) or underwent a stress echo guided
treatment or died in hospital or were lost to follow up.
Of those patients undergoing stress CMR, only 39%
(61/157) had evidence of inducible myocardial perfusion
defect. Putting these figures in a FFR guided approach
model our study showed an average saving of £302 per
patient or $1558 per patient in a UK based or US based
cost assessment, respectively.
Conclusions
Our study demonstrated that, less than 40% patients
undergoing PPCI with moderate to severe by-stander
non-culprit coronary artery disease need further revas-
cularisation. As a gatekeeper to complete revascularisa-
tion, stress CMR was also found to be a cheaper
management strategy in a cost analysis model when UK
or US-based costs were assumed.
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Table 1 Cost tariff
United Kingdom United States
Stress CMR (Cost per correct diagnosis) £548 (£623) $621 ($706)
Coronary angiography £1052 $2989
CA + FFR £1512 $3704
PCI £3676 $6529
Cost of PCI (follow on from FFR) £2164 $2825
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